Possible Role of Cost-Effectiveness of HPV Vaccination within the Decision Context on Inclusion of HPV in the Country-Specific National Immunization Programs
Mark Hermannes Rozenbaum, Carolin Grahlmann and Maarten Jacobus Postma
The Open Pharmacoeconomics & Health Economics Journal, 2010; 2: 1.
Electronic Publication Date: January 19, 2010Systematic Review of Urinary Incontinence and Overactive Bladder Costof- Illness Studies
Giovanni Aguzzi, Bartoli Simona and Tarricone Rosanna
The Open Pharmacoeconomics & Health Economics Journal, 2010; 2: 11.
Electronic Publication Date: April 22, 2010Cost-Effectiveness of Risedronate Treatment for Preventing Osteoporotic Fractures in Swiss Postmenopausal Women
Matthias Bischof, Marius Kränzlin, Heiner C. Bucher and Pedram Sendi
The Open Pharmacoeconomics & Health Economics Journal, 2010; 2: 25.
Electronic Publication Date: May 14, 2010Pharmaceutical Price Control Policy, Pharmaceutical Innovation, and Health Durability
Tetsuji Yamada, Chia-Ching Chen, Tadashi Yamada, I-Ming Chiu and John D. Worrall
The Open Pharmacoeconomics & Health Economics Journal, 2010; 2: 34.
Electronic Publication Date: June 10, 2010
